Skip to main content
Diabetic FootMetabolicPhase 4

What this study is

A multicenter, prospective, controlled clinical trial evaluating the efficacy of a single layer placental-based allograft and standard of care in the management of nonhealing diabetic foot ulcers.

What's being tested

  • XWRAP

    Intervention · OTHER

    Application of XWRAP + standard of care for up to 12 weeks.

Study details

Sponsor
Applied Biologics, LLC
Conditions
Diabetic Foot · Foot Ulcer · Ulcer Foot · DFU · Foot Ulcer Due to Type 2 Diabetes Mellitus · Foot Ulcer Due to Type 1 Diabetes Mellitus · Diabetic Foot Ulcer
Enrolling
60 people
Starts
2025-08-26
Est. completion
2027-08
Design
Open-label, single group, Phase 4
Record
View on ClinicalTrials.gov ↗